The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron. This is now the fifth iteration of the COVID vaccines, which have been updated regularly to keep up with the rapidly ...

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

The vaccine is part of a recommended vaccine regimen for children ... and attempts to address the rise of FLiRT omicron ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Omicron emerged in December 2021 ... The CDC recommends that people use its core prevention strategies, which includes ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

LTV is more effective than NTV and ETV against Mpro mutants, making it a promising candidate for treating drug-resistant strains of SARS-CoV-2.